MORGAN STANLEY - FINCH THERAPEUTICS GROUP INC ownership

FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 34 filers reported holding FINCH THERAPEUTICS GROUP INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of FINCH THERAPEUTICS GROUP INC
ValueSharesWeighting
Q1 2023$279
-27.7%
710
-11.7%
0.00%
Q4 2022$386
-61.4%
804
-2.3%
0.00%
Q3 2022$1,000
-98.7%
823
-97.0%
0.00%
Q2 2022$78,000
-39.5%
27,605
+7.1%
0.00%
Q1 2022$129,000
-52.7%
25,773
-6.0%
0.00%
Q4 2021$273,000
+11.9%
27,411
+45.9%
0.00%
Q3 2021$244,000
+1120.0%
18,789
+1212.1%
0.00%
Q2 2021$20,0001,4320.00%
Other shareholders
FINCH THERAPEUTICS GROUP INC shareholders Q1 2023
NameSharesValueWeighting ↓
Avenir Management Company, LLC 1,663,366$653,7033.23%
Bleichroeder LP 810,416$318,4930.07%
Ikarian Capital, LLC 237,553$93,3590.02%
LAKE STREET ADVISORS GROUP, LLC 739,136$2910.02%
Baupost Group 2,019,008$7930.01%
Proficio Capital Partners LLC 110,559$43,4500.01%
MSD Partners, L.P. 153,397$60,2850.01%
Ballentine Partners, LLC 143,603$56,4360.00%
SVB WEALTH LLC 253,054$99,4500.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 18,783$7,3820.00%
View complete list of FINCH THERAPEUTICS GROUP INC shareholders